Friday 20 April 2018
Contact US    |    Archive
Reuters
4 months ago

BRIEF-Aerie Pharmaceuticals Gets U.S. FDA Approval Of Glaucoma Drug

* AERIE PHARMACEUTICALS ANNOUNCES U.S. FDA APPROVAL OF RHOPRESSA® (NETARSUDIL OPHTHALMIC SOLUTION) 0.02% FOR THE LOWERING OF ELEVATED INTRAOCULAR PRESSURE IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTENSION

Read on the original site


هذه الصفحة هي مجرد قاریء تلقائي للأخبار باستخدام خدمة الـ RSS و بأن نشر هذه الأخبار هنا لاتعني تأییدها علی الإطلاق.
Hashtags:   

BRIEF

 | 

Aerie

 | 

Pharmaceuticals

 | 

Gets

 | 

FDA

 | 

Approval

 | 

Glaucoma

 | 

Drug

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Categories - Countries
All News
USA